SCHEMBL8339799

SCHEMBL8339799

Cc1nc2cc(F)ccc2n1CCCO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.57
TSHR P16473 3/20 0.48
NUDT1 P36639 1/20 0.48
BACE1 P56817 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.47
CYP1A2 P05177 1/20 0.44
MCHR1 Q99705 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RPS6KA5 O75582 1/20 0.42
KDM4E B2RXH2 1/20 0.42
RAD52 P43351 1/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
LMNA P02545 2/20 0.42
TP53 P04637 2/20 0.42
HDAC8 Q9BY41 1/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22965270 0.83 TBXA2R (0.50) KMT2ATSHRSMN1; SMN2KDM4EMAPT
SCHEMBL11195213 0.82 KMT2A (0.83) KMT2ATSHRNUDT1BACE1CYP1A2
SCHEMBL8339061 0.82 KMT2A (0.49) KMT2ATSHRCYP1A2SMN1; SMN2RPS6KA5
SCHEMBL8336656 0.80 LMNA (0.44) KMT2ATSHRSMN1; SMN2KDM4ELMNA
SCHEMBL8340061 0.80 NUDT1 (0.46) KMT2ATSHRNUDT1BACE1IRAK4
SCHEMBL10641373 0.80 KDM4E (0.64) KMT2ATSHRCYP1A2SMN1; SMN2RPS6KA5
SCHEMBL20206661 0.79 TDP1 (0.48) KMT2ASMN1; SMN2RPS6KA5KDM4ERAD52
SCHEMBL22965164 0.79 FAAH (0.58) KMT2ATSHRSMN1; SMN2RPS6KA5KDM4E
SCHEMBL8336757 0.78 LMNA (0.44) KMT2ATSHRCYP1A2SMN1; SMN2RPS6KA5
SCHEMBL6231609 0.77 KMT2A (0.51) KMT2ATSHRIRAK4RPS6KA5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5889010-A PSYCHOLOGICAL DISORDERS; UROGENITAL DISORDERS; COGNITION ACTIVATORS; NERVOUS SYSTEM DISORDERS; VISION DEFECTS; CONGESTIVE HEART FAILURE; DRUG ABRUSE; PARKINSON'S DISEASE;ANTIINFLAMMATORY AGENTS; ANTIALLERGENS PFIZER INC. (US) 1999-03-30 US disclosed
EP-0775118-A1 BENZIMIDAZOLE DERIVATIVES HAVING DOPAMINERGIC ACTIVITY PFIZER INC. (US) 1997-05-28 EP disclosed
WO-1996004250-A1 BENZIMIDAZOLE DERIVATIVES HAVING DOPAMINERGIC ACTIVITY PFIZER INC. (US) 1996-02-15 WO disclosed